T1	Disease 41 64	Cardiovascular diseases
#1	AnnotatorNotes T1	DOID:1287
T10	Biomarker 339 403	each 10 mm Hg increment in systolic blood pressure from baseline
T11	Chemical 350 352	Hg
T12	Biomarker 506 590	loci of the human D5R (hD5R), 4p15.1–16.1, and its pseudo genes, 1q21.1 2p11.1-p11.2
T13	Disease 606 628	essential hypertension
#3	AnnotatorNotes T13	DOID:10825
T14	Chemical 683 687	cAMP
T15	Biomarker 861 880	high blood pressure
T17	Disease 1180 1183	DCM
T18	Biomarker 1379 1382	D5R
T19	Chemical 1448 1453	NADPH
T2	Biomarker 87 99	hypertension
#8	AnnotatorNotes T2	D006973
T20	Disease 1533 1554	myocardial remodeling
#9	AnnotatorNotes T20	not found
T21	Biomarker 1597 1609	D5R mutation
T22	Disease 1618 1640	dilated cardiomyopathy
#10	AnnotatorNotes T22	DOID:12930
T23	Biomarker 1660 1676	oxidative stress
T25	Disease 1678 1692	D5R deficiency
T26	Biomarker 1703 1737	increase in NADPH oxidase activity
T27	Chemical 1715 1720	NADPH
T28	Gene-Protein 1888 1919	masculoaponeurotic fibrosarcoma
T3	Disease 113 116	DCM
T30	Chemical 1996 2011	NAD(P)H quinone
T32	Chemical 2039 2043	heme
T33	Gene-Protein 2297 2310	Phospholamban
T34	Chemical 2401 2405	Ca²⁺
T35	Disease 2462 2480	cardiac remodeling
#21	AnnotatorNotes T35	not found
T36	Disease 2494 2516	dilated cardiomyopathy
T5	Biomarker 135 157	ventricular dilatation
T6	Biomarker 162 202	impaired systolic and diastolic function
T9	Disease 312 334	cardiovascular disease
#26	AnnotatorNotes T9	DOID:1287
#2	AnnotatorNotes T3	DOID:12930
T4	Biomarker 224 258	blood pressure exceeds 160/95 mmHg
T7	Collection 135 202	ventricular dilatation and impaired systolic and diastolic function
R2	Association Arg1:T7 Arg2:T3	
R3	Risk-Factor Arg1:T4 Arg2:T3	
R4	Association Arg1:T10 Arg2:T9	
R5	Association Arg1:T12 Arg2:T13	
T38	Biomarker 1255 1276	mutant human D5R gene
T39	Gene-Protein 1425 1429	Nrf2
T40	Gene-Protein 1448 1461	NADPH oxidase
T41	Biomarker 1509 1528	ROS over-production
T42	Chemical 1509 1512	ROS
R6	Association Arg1:T18 Arg2:T20	
T43	Gene-Protein 1559 1566	ERK1/2/
T44	Gene-Protein 1566 1569	JNK
R7	Association Arg1:T21 Arg2:T22	
R8	Association Arg1:T23 Arg2:T22	
#4	AnnotatorNotes T23	D018384
T24	Gene-Protein 1715 1728	NADPH oxidase
T45	Gene-Protein 1777 1781	Nrf2
T46	Biomarker 1820 1959	failure of the transcription of a number of antioxidative genes via masculoaponeurotic fibrosarcoma (MAF) and antioxidant response elements
T47	Gene-Protein 1921 1924	MAF
T29	Gene-Protein 1997 2027	AD(P)H quinone 1 dehydrogenase
T31	Gene-Protein 2029 2033	NQO1
T48	Gene-Protein 2039 2055	heme oxygenase 1
T49	Gene-Protein 2057 2060	HO1
T50	Gene-Protein 2113 2119	ERK1/2
T51	Gene-Protein 2124 2127	JNK
T52	Gene-Protein 2178 2216	BCL2 associated X, apoptosis regulator
T53	Gene-Protein 2218 2221	BAX
T54	Gene-Protein 2244 2275	B aggressive lymphoma protein 2
T55	Gene-Protein 2277 2281	BAL2
T56	Gene-Protein 2283 2289	PARP14
T57	Disease 2063 2079	Oxidative stress
#7	AnnotatorNotes T57	D018384
T58	Gene-Protein 2312 2315	PLN
T59	GeneFamily 2414 2419	SERCA
T60	GeneFamily 2401 2412	Ca²⁺-ATPase
T61	Gene-Protein 2432 2438	ATP2A2
T62	Collection 2462 2516	cardiac remodeling and finally, dilated cardiomyopathy
T63	Biomarker 2297 2310	Phospholamban
#11	AnnotatorNotes T63	C016056
R9	Risk-Factor Arg1:T63 Arg2:T62	
T64	Gene-Protein 2545 2580	Kelch-like ECH Associated Protein 1
T65	Gene-Protein 2582 2587	Keap1
T66	Gene-Protein 2599 2603	Nrf2
T67	Gene-Protein 2663 2673	proteasome
T68	Biomarker 659 667	hD5F¹⁷³ᴸ
T69	Biomarker 672 713	diminished cAMP activity and D5R function
T70	Biomarker 839 847	hD5F¹⁷³ᴸ
T8	Biomarker 885 904	cardiac hypertrophy
T37	Biomarker 974 982	hD5F¹⁷³ᴸ
T71	Biomarker 1204 1212	hD5F¹⁷³ᴸ
R10	Association Arg1:T71 Arg2:T17	
T72	Gene-Protein 524 527	D5R
#12	AnnotatorNotes T72	HGNC:3026
T73	Gene-Protein 529 533	hD5R
#14	AnnotatorNotes T73	HGNC:3026
T74	Gene-Protein 701 704	D5R
T75	Gene-Protein 774 777	D5R
T76	Gene-Protein 1268 1271	D5R
T77	Gene-Protein 1379 1382	D5R
T78	Gene-Protein 1597 1600	D5R
T79	Gene-Protein 1678 1681	D5R
T80	Gene-Protein 2518 2521	D5R
R1	Association Arg1:T2 Arg2:T1	
#5	AnnotatorNotes T8	D006332
T16	Collection 1703 1959	increase in NADPH oxidase activity (I), and prevents the translocation of Nrf2 into the nucleus (II), resulting in a failure of the transcription of a number of antioxidative genes via masculoaponeurotic fibrosarcoma (MAF) and antioxidant response elements
R11	Association Arg1:T16 Arg2:T25	
